-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Adial Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2024.
- Adial Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $202K, a 72.6% decline year-over-year.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.75M, a 48.2% decline from 2022.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.37M, a 20.4% decline from 2021.
- Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.24M, a 199% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)